420 related articles for article (PubMed ID: 31078050)
1. Nanomaterial designing strategies related to cell lysosome and their biomedical applications: A review.
Rathore B; Sunwoo K; Jangili P; Kim J; Kim JH; Huang M; Xiong J; Sharma A; Yang Z; Qu J; Kim JS
Biomaterials; 2019 Aug; 211():25-47. PubMed ID: 31078050
[TBL] [Abstract][Full Text] [Related]
2. Pro-Death or Pro-Survival: Contrasting Paradigms on Nanomaterial-Induced Autophagy and Exploitations for Cancer Therapy.
Zhang Y; Zhang L; Gao J; Wen L
Acc Chem Res; 2019 Nov; 52(11):3164-3176. PubMed ID: 31621285
[TBL] [Abstract][Full Text] [Related]
3. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity.
Stern ST; Adiseshaiah PP; Crist RM
Part Fibre Toxicol; 2012 Jun; 9():20. PubMed ID: 22697169
[TBL] [Abstract][Full Text] [Related]
4. In Search of a Converging Cellular Mechanism in Nanotoxicology and Nanomedicine in the Treatment of Cancer.
Gulumian M; Andraos C
Toxicol Pathol; 2018 Jan; 46(1):4-13. PubMed ID: 29034767
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal targeting strategies for design and delivery of bioactive for therapeutic interventions.
Sharma A; Vaghasiya K; Ray E; Verma RK
J Drug Target; 2018 Mar; 26(3):208-221. PubMed ID: 28862054
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications.
Ai X; Hu M; Wang Z; Zhang W; Li J; Yang H; Lin J; Xing B
Bioconjug Chem; 2018 Apr; 29(4):838-851. PubMed ID: 29509403
[TBL] [Abstract][Full Text] [Related]
7. Exploiting endocytosis for nanomedicines.
Akinc A; Battaglia G
Cold Spring Harb Perspect Biol; 2013 Nov; 5(11):a016980. PubMed ID: 24186069
[TBL] [Abstract][Full Text] [Related]
8. Future of nanotherapeutics: Targeting the cellular sub-organelles.
Ma X; Gong N; Zhong L; Sun J; Liang XJ
Biomaterials; 2016 Aug; 97():10-21. PubMed ID: 27155363
[TBL] [Abstract][Full Text] [Related]
9. Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment.
Ma X; Wu Y; Jin S; Tian Y; Zhang X; Zhao Y; Yu L; Liang XJ
ACS Nano; 2011 Nov; 5(11):8629-39. PubMed ID: 21974862
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Systems Go Extracellular.
Buratta S; Tancini B; Sagini K; Delo F; Chiaradia E; Urbanelli L; Emiliani C
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32276321
[TBL] [Abstract][Full Text] [Related]
11. Designing polymer conjugates as lysosomotropic nanomedicines.
Duncan R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
[TBL] [Abstract][Full Text] [Related]
12. Graphene oxide induces p62/SQSTM-dependent apoptosis through the impairment of autophagic flux and lysosomal dysfunction in PC12 cells.
Feng X; Chen L; Guo W; Zhang Y; Lai X; Shao L; Li Y
Acta Biomater; 2018 Nov; 81():278-292. PubMed ID: 30273743
[TBL] [Abstract][Full Text] [Related]
13. Giant Cellular Vacuoles Induced by Rare Earth Oxide Nanoparticles are Abnormally Enlarged Endo/Lysosomes and Promote mTOR-Dependent TFEB Nucleus Translocation.
Lin J; Shi SS; Zhang JQ; Zhang YJ; Zhang L; Liu Y; Jin PP; Wei PF; Shi RH; Zhou W; Wen LP
Small; 2016 Nov; 12(41):5759-5768. PubMed ID: 27593892
[TBL] [Abstract][Full Text] [Related]
14. Tunable resistive pulse sensing: potential applications in nanomedicine.
Sivakumaran M; Platt M
Nanomedicine (Lond); 2016 Aug; 11(16):2197-214. PubMed ID: 27480794
[TBL] [Abstract][Full Text] [Related]
15. Endocytic mechanisms for targeted drug delivery.
Bareford LM; Swaan PW
Adv Drug Deliv Rev; 2007 Aug; 59(8):748-58. PubMed ID: 17659804
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology for neurodegenerative disorders.
Re F; Gregori M; Masserini M
Nanomedicine; 2012 Sep; 8 Suppl 1():S51-8. PubMed ID: 22640910
[TBL] [Abstract][Full Text] [Related]
17. LYST affects lysosome size and quantity, but not trafficking or degradation through autophagy or endocytosis.
Holland P; Torgersen ML; Sandvig K; Simonsen A
Traffic; 2014 Dec; 15(12):1390-405. PubMed ID: 25216107
[TBL] [Abstract][Full Text] [Related]
18. Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?
Panzarini E; Dini L
Mol Pharm; 2014 Aug; 11(8):2527-38. PubMed ID: 24921216
[TBL] [Abstract][Full Text] [Related]
19. Biomedical Applications of Nanomaterials as Therapeutics.
Ng CT; Baeg GH; Yu LE; Ong CN; Bay BH
Curr Med Chem; 2018; 25(12):1409-1419. PubMed ID: 28393698
[TBL] [Abstract][Full Text] [Related]
20. DNA nanomaterials for preclinical imaging and drug delivery.
Jiang D; England CG; Cai W
J Control Release; 2016 Oct; 239():27-38. PubMed ID: 27527555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
